EmergencyKT: New Onset Diabetes, Non-DKA Definition: ED patient with newly discovered hyperglycemia, >200 mg %

Similar documents
DIABETES MELLITUS. IAP UG Teaching slides

DAYTON CHILDREN S HOSPITAL CLINICAL PRACTICE GUIDELINES

Diabetic Ketoacidosis: When Sugar Isn t Sweet!!!

DKA : Diabetic Ketoacidosis & HHS: Hyperlgycemic Hyperosmolar Syndrome Protocol. Glycemic Task Force September 2014

DKA Adult ICU Powerplan

Estimation of Blood Glucose level. Friday, March 7, 14

Improved IPGM: Demonstrating the Value to both Patients and Hospitals

Uncomplicated Diabetes Mellitus in Dogs Basics

American Diabetes Association Standards of Medical Care in Diabetes 2018: Latest Updates

Non-insulin treatment in Type 1 DM Sang Yong Kim

Welcome Everyone. Monitoring, Sick Days, Inpatient Management - Objectives. Mrs. Jones has new diabetes. She asks you: Page 1

Diabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016

APPENDIX American Diabetes Association. Published online at

2017 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members

Distinguishing T1D vs. T2D in Childhood: a case report for discussion

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Special Situations. Askiel Bruno, MD, MS Protocol PI

Diabetic Ketoacidosis

Q99: At what plasma glucose level would glycosuria be expected? Q101: What is the cause of polydipsia in the hypoglycemia?

Chapter 37: Exercise Prescription in Patients with Diabetes

The Hospitalized Child with Diabetes/Hyperglycemia: Don t Sugar Coat It

Diabetic Emergencies: Ketoacidosis and the Hyperglycemic Hyperosmolar State. Adam Bursua, Pharm.D., BCPS

Figure 2.1: Glucose meter

Diabetes Care Program of Nova Scotia (DCPNS)

Incorporating CGM Into Clinical Decision Making. Etie Moghissi, MD, FACE Clinical Associate Professor, David Geffen School of Medicine UCLA

Advances in Diabetes Care Technologies

Chapter Goal. Learning Objectives 9/12/2012. Chapter 25. Diabetic Emergencies

ACUTE METABOLIC COMPLICATIONS IN DIABETES Arleta Rewers, MD, PhD

Influence of Special Needs: Presentation for IOM Committee on Examination of the Adequacy of Food Resources and SNAP Benefits

LOW SUGAR: CAUSES, COMPLICATIONS AND MANAGEMENT OF HYPOGLYCEMIA

Diabetic Ketoacidosis

Neurodevelopmental Risk?

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Safety, Tolerability, Pharmacokinetics,and Pharmacodynamics of Multiple Rising Doses of Empagliflozin in Patients with Type 2 Diabetes Mellitus

Nursing Care of the Resident with Diabetes Mellitus

39 year old F with sickle cell anemia presenting with pain crisis. Jess Hwang 11/8/12

Hypoglycemia Reduction STARTER PACK WEBINAR #1

Diabetic Equipment and Supplies

2015 Diabetes. Program Evaluation. Our mission is to improve the health and quality of life of our members

American Diabetes Association 2018 Guidelines Important Notable Points

Diabetes Case Study: Co-morbidity of Nonadherence

Initiation and Titration of Insulin in Diabetes Mellitus Type 2

Diabetes Case Study: Co-morbidity of Nonadherence Maureen Dever, MSN, CRNP, PPCNP.BC, CDE PENS 5/18

Advances in Diabetes Care Technologies

WILL YOU USE HBA1C TO SCREEN & MONITOR DIABETES? Dr. Amany Mousa

Pharmacy Coverage Guidelines are subject to change as new information becomes available.

Peripartum and Postpartum Management of Diabetes

Use of Real-World Data for Population Surveillance and Monitoring. Kasia Lipska, MD Yale School of Medicine November 17 th, 2018.

Key Elements in Managing Diabetes

Journal Club September 29, Vanessa AKIKI PGYlII Internal Medicine

Learning Objectives. At the conclusion of this module, participants should be better able to:

Diabetes Self-Management Education Record

ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES

HIMSS Davies Enterprise Award Submission

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Insulinoma - 72 hour Fast Protocol - RNS Endocrinology

DKA/HHS Pathway Phase 1 (Adult) Insulin Potassium Bicarbonate

Metformin Hydrochloride

SYNOPSIS. Administration: subcutaneous injection Batch number(s):

associated with serious complications, but reduce occurrences with preventive measures

Individualizing Treatment Plans for Older Adults With T2DM

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center

CDE Exam Preparation Presented by Wendy Graham RD CDE May 4, 2017

Brigham and Women s Hospital Type 2 Diabetes Management Program Physician Pharmacist Collaborative Drug Therapy Management Protocol

Current Glucometers. Junior s s Glucose Log. All have advantages and disadvantages Answer 2

Sponsor: Sanofi Drug substance(s): Lantus /insulin glargine. Study Identifiers: U , NCT Study code: LANTUL07225

Test strip reading - Cats Negative Trace

Physical Activity/Exercise Prescription with Diabetes

JMSCR Vol 06 Issue 10 Page October 2018

AACE Module on Patient Safety in Inpatient Diabetes Care

Management of DM in Older Adults: It s not all about sugar! Who needs treatment for DM? Peggy Odegard, Pharm.D., BCPS, CDE

Αναγκαιότητα και τρόπος ρύθμισης του διαβήτη στους νοσηλευόμενους ασθενείς

Introduction. Methods

Food Insecurity & Health

Insulin Delivery and Glucose Monitoring Methods for Diabetes Mellitus: Comparative Effectiveness

These results are supplied for informational purposes only.

The Diabetic Athlete. Matt Bayes, MD, CAQSM BlueTail Medical Group St. Louis, MO

Deepika Reddy MD Department of Endocrinology

About the Highmark Foundation

DIABETES WITH PREGNANCY

Your pet s diabetes is manageable

Nova Scotia Guidelines for Acute Coronary Syndromes (Updating the 2008 Diabetes sections of the Guidelines)

DIABETES AND PREGNANCY. CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor

Diagnosis and Management of Type 2 Diabetes Mellitus in Adults

RN Diabetes Medication Titration Protocol

DRUG ALLERGIES WT: KG

Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES

A collaborative approach to managing Diabetes in Long Term Care

Diabetes, sugar. Greenville Veterinary Clinic LLC 409 E. Jamestown Rd. Greenville, PA (724)

Learning Objectives. Perioperative SWEET Success

A Children s Bedtime Story

Discharge Checklist. Patient Education Transplant Services. For a kidney/pancreas transplant

Benefit Criteria for Diabetic Equipment and Supplies Home Health Services Changing July 1, 2011

Improving the Accuracy of Hemoglobin A 1c. : Your Help Is Needed

How Doctors Choose Medicines when Treating Patients with Type 2 Diabetes

DEMYSTIFYING INSULIN THERAPY

APIDRA (insulin glulisine) injection vial APIDRA SOLOSTAR (insulin glulisine) subcutaneous solution pen-injector

VS: BP 165/90, P 98, RR 18, T 37 C; waist circ 38 in, Wt 240 lbs (109 kg), Ht 5'8''

Diabetes Mellitus Case Study

23-Aug-2011 Lixisenatide (AVE0010) - EFC6014 Version number: 1 (electronic 1.0)

Diabetes Update: Intensifying Insulin Therapy Nuts, Bolts and Other Items

Transcription:

EmergencyKT: New Onset, Non-DKA Definition: ED patient with newly discovered hyperglycemia, >200 mg % Obtain: CBCD EP1 VBG Serum Ketone Hemoglobin A1c (for follow up) UA β-hcg (female at risk for pregnancy) Asymptomatic Symptomatic Symptomatic Without polydipsia/polyuria (P/P) Polydipsia/polyuria (P/P) Polydipsia/polyuria (P/P) Serum glucose < 250mg % Serum glucose < 400 mg/dl Serum glucose 400-600 mg/dl No admittable or serious Anion Gap < 15 Anion Gap < 15 concomitant illness Creatinine < 1.5 Creatinine < 1.5 No admittable or serious No admittable or serious concomitant illness concomitant illness ED Treatment: ED Treatment: ED Treatment: None 1. 1-2 liters rmal saline 1. 2-3 liters rmal saline 2. 2-5 units Humolog insulin 2. 5-10 units Humolog insulin subcutaneous subcutaneous 3. Recheck EP1 in 1-2 hours 3. Recheck EP1 in 2 hours Disposition: Disposition: Disposition: 1. Brief diabetes education and 1. Glucose<300 mg % (ideally <250) 1. Glucose<300 mg % (ideally <250) diabetes discharge documents 2. Patient competent, good home 2. Patient competent, good home setting setting 2. Follow-up with PCP or urgent 3. Brief diabetes education and 3. Brief diabetes education and medicine clinic <7 days if diabetes discharge documents diabetes discharge documents PCP 4. Start metformin 500 mg. qd 4. Start metformin 500 mg. qd 3. If clinic follow up available 5. Follow-up with PCP or urgent 5. Follow-up with PCP or urgent consider referral to Adele Corbin medicine clinic <7 days if medicine clinic <7 days if (at Hoxworth diabetes clinic) for PCP PCP urgent DM follow up care. 6. Referral to Adele Corbin (at 6. Referral to Adele Corbin (at Call 584-0942 and leave Hoxworth diabetes clinic) for Hoxworth diabetes clinic) for up to date patient contact urgent DM follow up. Call urgent DM follow up. Call information 584-0942 and leave 584-0942 and leave up to date patient contact up to date patient contact information information

EmergencyKT: Use of HbA1c in the Emergency Department What is a Hemoglobin A1c (HbA1c)? HbA1c represents a patient s average glucose level over the last 1-4 months. HbA1c measures the percentage of glycosylated hemoglobin in the blood and thus reflects the average glucose level over the life of a red blood cell (120 days) and the hemoglobin it contains. Because of the constant turning over of red blood cells, more recent glucose levels (ie. the last few weeks) have a greater effect on the HbA1c value than do those from 8 or 12 weeks ago. It is estimated that half of an HbA1c value is attributable to the previous month s glucose level, a further quarter to the month before that, and the other quarter to the two months before that. Since the HbA1c value is t influenced by daily fluctuations in blood glucose concentration, it should t be used to monitor day-to-day blood glucose concentrations and to adjust insulin treatment. Moreover, the HbA1c value may t reflect the day-to-day presence or absence of hyperglycemia and/or hypoglycemia. HbA1c level may be falsely increased in patients with: kidney failure, chronic excessive alcohol intake (Vit B12 and foliate deficiency), untreated iron deficient anemia, and hypertriglyceridemia HbA1c level may be falsely decreased in patients with: acute or chronic blood loss, sickle cell disease, hemolytic anemia/thalassemia. Why obtain an HbA1c in the Emergency Department? Without primary care and proper diabetes management it is extremely difficult for many diabetics to control their glucose levels. It is this lack of glycemic control that is ultimately responsible for the host of debilitating and potentially life threatening health complications associated with poorly controlled diabetes. Diabetic patients who present to the emergency department (and who lack adequate primary care or who are in need of improved diabetes management, education and/or follow up) should have their HbA1c level obtained. The result can then be used to assess the patient s current glycemic control and determine their urgency of needed follow up. The implementation of this tool could significantly reduce the number of unnecessary emergency department visits by decreasing the number of diabetic patients who use the emergency department as a means of obtaining primary care and by decreasing the incidence and severity of diabetic related complications that require emergency department treatment. This also has the potential to reduce costs by decreasing the number of emergency department visits and their related work ups. HbA1c % Average Serum Glucose mg/dl < 5.0 5.4-6.4 6.5-7.0 7.1-8.0 8.1-9.0 9.1-11.9 > 12 < 81 94-127 130-147 150-180 184-214 217-310 > 314 Marginally Kwn Diabetic Increased risk for severe hypoglycemia adverse events including coma, seizures and death Excellently Controlled Well Controlled Take action to lower average glucose levels Note: HbA1c < 8% may be appropriate for patients with a history of severe hypoglycemia, advanced age or severe comorbidities. Poorly Very Poorly Severely Elevated Extremely Poor Management New Onset Hyperglycemia Unlikely (Pre Diabetic) Increased risk for diabetes and diabetes related complications Borderline

Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Control and Complications Trial. The Journal of the American Medical Association. 1996; 17:1409-1415 Ginde AA, Talley BE, Trent SA. Raja AS, Sullivan AF, Camargo CA. Referral of Discharged Emergency Department Patients to Primary and Specialty Care Follow-up. Journal of Emergency Medicine. May 2011; Retrieved online on April 9, 2011 from website: http://www.sciencedirect.com.proxy.libraries.uc.edu/science/article/pii/s0736467911010286 Standards of Medical Care in 2010. Care. January 2010; 33:511-561

EmergencyKT: Disposition for Hyperglycemic/Diabetic Patients Discharged from the ED 1. Hyperglycemia identified and treated 2. All applicable lab work obtained: CBCD, EP1, Mag, Phos, VBG, HbA1c, Serum Ketones, UA/Preg 3. Underlying cause of blood sugar variation/infection identified and treated 1. Glucose ideally < 250 2. No Recent Hypoglycemia 3. Vital Signs Stable 4. Ability to tolerate PO 5. Anion Gap < 15 6. Competent to perform basic diabetic care (able to recognize hyperglycema and hypoglycemia) HbA1c % Control card. Type 2 - Cell Biology. Obtained online on April 14 from website: http://pt851.wikidot.com/ type-2-diabetes-cell-biology <5.9 6-7 7.1-8 8.1-9 9.1-11 >12 Increased Hypoglycemic Risk (consider DM clinic referral) yes Consider Diabetic Clinic Referral yes Consider Admission (for intensive glucose management) Referral to Adele Corbin (@ Hoxworth diabetes clinic) for urgent DM follow up. Call 584-0942 and leave up to date patient contact Information, brief patient history and current HbA1c result (if available at time of discharge) Follow up with PCP < 7 days If PCP, consider urgent medicine clinic referral Ensure that patient has all needed diabetic supplies including glucometers, and Rx refill for supplies if needed (free glucometers and generic Rx forms for common medications and DM supplies can be found in the radio room, see DM Committee member if ne are available). Brief diabetes education and discharge instructions specific for diabetes (found on CPQE). Follow up with PCP If PCP, consider urgent medicine clinic referral

Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Control and Complications Trial. The Journal of the American Medical Association. 1996; 17:1409-1415 Ginde AA, Talley BE, Trent SA. Raja AS, Sullivan AF, Camargo CA. Referral of Discharged Emergency Department Patients to Primary and Specialty Care Follow-up. Journal of Emergency Medicine. May 2011; Retrieved online on April 9, 2011 from website: http://www.sciencedirect.com.proxy.libraries.uc.edu/science/article/pii/s0736467911010286 Standards of Medical Care in 2010. Care. January 2010; 33:511-561